pindolol has been researched along with haloperidol in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (28.13) | 18.7374 |
| 1990's | 7 (21.88) | 18.2507 |
| 2000's | 10 (31.25) | 29.6817 |
| 2010's | 6 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kompa, AR; Molenaar, P; Pak, HS; Roberts, SJ; Summers, RJ | 1 |
| Futuro-Neto, HA; Pires, JG; Silva, SR | 1 |
| Kalkman, HO; Soar, J | 1 |
| Broadley, KJ; Williamson, KL | 1 |
| Jensen, CF | 1 |
| Davanzo, EA; McMillen, BA; Scott, SM | 1 |
| Forler, C; Fozard, JR; Middlemiss, DN; Tricklebank, MD | 1 |
| Finch, CE; Gal, J; Molinoff, PB; Pittman, RN; Severson, JA | 1 |
| Greendyke, RM; Gulya, A | 1 |
| Amenta, F; Cavallotti, C; Collier, WL; Iacopino, L | 1 |
| Eichelman, B; Hegstrand, LR | 1 |
| Amenta, F; Collier, WL; De Rossi, M | 1 |
| Kato, N; Masui, A; Takahashi, K; Tsunashima, K | 1 |
| Futuro-Neto, HA; Pires, JG; Ramage, AG; Silva, SR | 1 |
| Sket, D; Sprah, L; Zivin, M | 1 |
| Goodman, WK | 1 |
2 review(s) available for pindolol and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Obsessive-compulsive disorder: diagnosis and treatment.
Topics: Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Obsessive-Compulsive Disorder; Pindolol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
30 other study(ies) available for pindolol and haloperidol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Localization of (-)-[125I]cyanopindolol binding in guinea-pig heart: characteristics of non-beta-adrenoceptor related binding in cardiac pacemaker and conducting regions.
Topics: Alprenolol; Animals; Ascorbic Acid; Binding Sites; Ethanolamines; Female; Guinea Pigs; Haloperidol; Heart Conduction System; Isoproterenol; Male; Myocardium; Peroxidase; Phentolamine; Pindolol; Propanolamines; Propranolol; Protein Binding; Receptors, Adrenergic, beta; Serotonin; Thiophenes; Trachea | 1992 |
Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Topics: Animals; Buspirone; Catalepsy; Chlorpromazine; Clomipramine; Female; Haloperidol; Male; Mice; Pindolol; Receptors, Serotonin | 1990 |
Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dioxanes; Haloperidol; Male; Motor Activity; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Tetrahydronaphthalenes | 1990 |
Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
Topics: Animals; Cocaine; Desipramine; Dibenzylchlorethamine; Epinephrine; Haloperidol; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Norepinephrine; Pindolol; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Stimulation, Chemical; Timolol | 1989 |
Hypersexual agitation in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Haloperidol; Humans; Hydroxyzine; Male; Pindolol; Sex Offenses; Sexual Behavior | 1989 |
Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Catalepsy; Drug Interactions; Haloperidol; Male; Methysergide; Morphine; Pindolol; Piperazines; Rats | 1988 |
Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Betaxolol; Haloperidol; Ketanserin; Male; Pindolol; Piperidines; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reserpine; Spiperone | 1985 |
Genetic influence on the regulation of beta adrenergic receptors in mice.
Topics: Age Factors; Animals; Cerebral Cortex; Haloperidol; Hydroxydopamines; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Oxidopamine; Pindolol; Propranolol; Receptors, Adrenergic, beta; Species Specificity | 1986 |
Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital.
Topics: Adult; Aged; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Neurocognitive Disorders; Phenobarbital; Phenytoin; Pindolol; Rage; Thioridazine; Violence | 1988 |
Age-associated decrease of dopamine-sensitive adenylate cyclase in rabbit renal artery.
Topics: Adenylyl Cyclases; Age Factors; Animals; Cyclic AMP; Dopamine; Fluphenazine; Haloperidol; Male; Phentolamine; Pindolol; Rabbits; Receptors, Dopamine; Renal Artery | 1984 |
Increased shock-induced fighting with supersensitive beta-adrenergic receptors.
Topics: Aggression; Animals; Brain; Cell Membrane; Electroshock; Haloperidol; Humans; Male; Metoprolol; Pindolol; Posture; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1983 |
Dopamine-sensitive adenylate-cyclase in rabbit superior mesenteric artery.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Female; Fluphenazine; Haloperidol; In Vitro Techniques; Male; Mesenteric Arteries; Phentolamine; Pindolol; Rabbits; Receptors, Dopamine; Theophylline | 1984 |
The effect of delta sleep-inducing peptide (DSIP) on the changes of body (core) temperature induced by serotonergic agonists in rats.
Topics: Animals; Body Temperature Regulation; Delta Sleep-Inducing Peptide; Dopamine; Haloperidol; Male; Pindolol; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists | 1994 |
Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.
Topics: Animals; Buspirone; Catalepsy; Cisapride; Female; Granisetron; Haloperidol; Male; Mice; Pindolol; Piperidines; Quinolines; Serotonin Antagonists; Time Factors | 1993 |
The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzazepines; Dose-Response Relationship, Drug; Genes, fos; Haloperidol; Lysergic Acid; Male; Oxidopamine; Pindolol; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1996 |